Journal
JOURNAL OF BIOMEDICAL RESEARCH
Volume 30, Issue 5, Pages 361-372Publisher
NANJING MEDICAL UNIV
DOI: 10.7555/JBR.30.20150131
Keywords
Alzheimer's disease; autoimmune; autoantibody; biomarker; pathogenesis; immunotherapy
Categories
Funding
- National Institute of Health [HL117652]
- Academic Health Center (Faculty Research Development Program) of the University of Minnesota
Ask authors/readers for more resources
Alzheimer's disease (AD) is a prevalent and debilitating neurodegenerative disorder in the elderly. The etiology of AD has not been fully defined and currently there is no cure for this devastating disease. Compelling evidence suggests that the immune system plays a critical role in the pathophysiology of AD. Autoantibodies against a variety of molecules have been associated with AD. The roles of these autoantibodies in AD, however, are not well understood. This review attempts to summarize recent findings on these autoantibodies and explore their potential as diagnostic/prognostic biomarkers for AD, their roles in the pathogenesis of AD, and their implications in the development of effective immunotherapies for AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available